Clinical Trials Browser

fosaprepitant × Gastrointestinal × Clear all

NCT01504711 2021-04-08

Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Phase NA Completed

30 enrolled 12 charts

Gastrointestinal

Gastrointestinal Neoplasms

NCT01344304 2021-02-26

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms